Respiratory Diseases - BMI may not be best obesity indicator to evaluate lung cancer risk, study suggests
Can't see this email? View it online
   
  Respiratory Diseases  
  The latest respiratory diseases news from News Medical  
 Single-cell map offers a new immunotherapy target for lung cancer treatmentSingle-cell map offers a new immunotherapy target for lung cancer treatment
 
Researchers at The University of Texas MD Anderson Cancer Center have developed a first-of-its-kind spatial atlas of early-stage lung cancer and surrounding normal lung tissue at single-cell resolution, providing a valuable resource for studying tumor development and identifying new therapeutic targets.
 
   BMI may not be best obesity indicator to evaluate lung cancer risk, study suggestsBMI may not be best obesity indicator to evaluate lung cancer risk, study suggests
 
New research published in the Journal of Thoracic Oncology suggests the method used to calculate how obesity is measured may affect whether it is considered a risk factor for lung cancer.
 
   New methods may lead to optimal treatment for lung cancerNew methods may lead to optimal treatment for lung cancer
 
Today as they did 100 years ago, doctors diagnose cancer by taking tissue samples from patients, which they usually fix in formalin for microscopic examination.
 
 Early-stage lung cancer coopts macrophages to help tumors invade lung tissues
 
Early-stage lung cancer coopts macrophages to help tumors invade lung tissuesImmune cells that normally repair tissues in the body can be fooled by tumors when cancer starts forming in the lungs and instead help the tumor become invasive, according to a surprising discovery reported by Mount Sinai scientists in Nature in June.
 
 
 Research shows how circadian control of glucose production is disrupted during lung cancer progression
 
Research shows how circadian control of glucose production is disrupted during lung cancer progressionNew research from the University of California, Irvine reveals how the circadian regulation of glucose production in the liver is lost during lung cancer progression, and how the resulting increase in glucose production may fuel cancer cell growth.
 
 
 PET/CT images can be used to measure biomarker levels, predict lung cancer outcomes
 
PET/CT images can be used to measure biomarker levels, predict lung cancer outcomesTests that analyze biomarkers are used during cancer management to guide treatment and provide information about patient prognosis.